Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan J Done

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Breast Cancer Research and Treatment|March 5, 2013
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysisEileen Rakovitch, Sharon Nofech-Mozes, Steven A Narod, et al.
International Journal of Radiation Oncology, Biology, Physics|May 28, 2013
Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysisEileen Rakovitch, Steven A Narod, Sharon Nofech-Moses, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breastNafisha Lalani, Lawrence Paszat, Rinku Sutradhar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast RadiotherapyFei-Fei Liu, Wei Shi, Susan J Done, et al.
Breast (Edinburgh, Scotland)|August 8, 2017
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomyEileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, et al.
Springerplus|July 18, 2015
Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysisJonathan Klein, Iwa Kong, Lawrence Paszat, et al.
Molecular Cancer Research : MCR|September 24, 2021
Mutations in Noncoding <i>Cis</i>-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast CancerSamah El Ghamrasni, Rene Quevedo, James Hawley, et al.
NPJ Breast Cancer|December 15, 2025
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancerMartin Rotbauer, Melanie Dawe, Kevin C J Nixon, et al.
Cancer Research|September 25, 2015
Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer PatientsKatherine L Wright, Jessica R Adams, Jeff C Liu, et al.
Plos One|February 25, 2012
Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survivalThomas R Cawthorn, Juan C Moreno, Moyez Dharsee, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Breast Cancer Research and Treatment|March 5, 2013
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysisEileen Rakovitch, Sharon Nofech-Mozes, Steven A Narod, et al.
International Journal of Radiation Oncology, Biology, Physics|May 28, 2013
Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysisEileen Rakovitch, Steven A Narod, Sharon Nofech-Moses, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breastNafisha Lalani, Lawrence Paszat, Rinku Sutradhar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast RadiotherapyFei-Fei Liu, Wei Shi, Susan J Done, et al.
Breast (Edinburgh, Scotland)|August 8, 2017
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomyEileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, et al.
Springerplus|July 18, 2015
Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysisJonathan Klein, Iwa Kong, Lawrence Paszat, et al.
Molecular Cancer Research : MCR|September 24, 2021
Mutations in Noncoding <i>Cis</i>-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast CancerSamah El Ghamrasni, Rene Quevedo, James Hawley, et al.
NPJ Breast Cancer|December 15, 2025
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancerMartin Rotbauer, Melanie Dawe, Kevin C J Nixon, et al.
Cancer Research|September 25, 2015
Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer PatientsKatherine L Wright, Jessica R Adams, Jeff C Liu, et al.
Plos One|February 25, 2012
Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survivalThomas R Cawthorn, Juan C Moreno, Moyez Dharsee, et al.
Pageof 9